We have some exciting news to share! The Motley Fool UK has now become an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. We’ll be introducing a new name and brand over the coming weeks — we're very excited to share it with you and embark on this new chapter together!

Why FTSE 100 firm AstraZeneca’s shares fell and Codemasters’ stock soared 20% today

FTSE 100 pharma giant AstraZeneca is seeing its share price fall today, but UK gaming stock Codemasters is flying on takeover news.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100 index opened, very slightly up this morning on news that Brexit negotiations will continue. This bolstered the pound, but concerns of disruption to supply chains and restrictions on UK citizens working in Europe remain. Meanwhile, in the US, hopes for a stimulus bill continue to be discussed, but nothing is yet confirmed and is still suppressing share prices.

AstraZeneca share price falls

FTSE 100 pharma giant AstraZeneca (LSE:AZN) is buying US drugmaker Alexion Pharmaceuticals in a surprise diversification away from its cancer portfolio to take a stake in rare-disease and immunology drugs. In a deal reportedly worth £29bn ($39bn), this is its largest ever transaction.

CEO Pascal Soriot has driven a turnaround in the company’s fortunes in recent years. He fought off a bid from Pfizer to buy out AstraZeneca back in 2014 and has worked hard to develop a ground-breaking set of cancer drugs.

The AstraZeneca share price has therefore steadily risen over the past two years. It was also encouraged this year by its involvement in creating a Covid-19 vaccine in collaboration with Oxford University. This has been largely successful. It’s coming in cheaper and more logistically viable than Pfizer’s offering, but still must get through some final testing hurdles.

In light of its buoyant share price, the CEO wants to add value by increasing market share. This is the reason for the mega purchase of Alexion. Nevertheless, some shareholders don’t see the value and that’s why the FTSE 100 company’s share price fell almost 7% at the opening bell.

The CEO believes this acquisition will increase earnings per share, which in turn will help to justify its massive price-to-earnings ratio (P/E) of 99. AstraZeneca offers shareholders a 2.7% dividend yield.

Codemasters to be bought by Electronic Arts

Meanwhile, shares in AIM-listed Codemasters Group Holdings (LSE:CDM) jumped over 20% this morning. This was on the back of weekend news that Electronic Arts wants to buy it. NASDAQ-listed Electronic Arts has a market cap of £30bn ($40bn) and P/E of 30. The massive US computer games company has agreed to buy Codemasters for £945m ($1.2bn).

This was after outbidding rival US company Take-Two Interactive Software. The maker of Grand Theft Auto had offered £759m ($1bn) in a cash-and-stock deal. The Codemasters share price is up 82% since Take Two first made its bid in September.

Codemasters’ ongoing success largely comes from the popularity of its racing simulator games, including Formula One, Project Cars and Dirt. Leading video games publisher Electronic Arts, on the other hand, makes Fifa, Apex Legends, Battlefield, Need for Speed, Star Wars and many more.

The Codemasters share price has now risen 129% year-to-date. It’s also up 222% since the 30-year-old company publicly listed in 2018. Tech and gaming companies are particularly popular at the moment and have done very well in 2020. This is spurring the drive for big gaming companies to snap up promising smaller entities. Investing in tech and health companies remains popular among retail investors despite skyrocketing valuations and concerns of a bubble in the tech sector.

Kirsteen has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended Take-Two Interactive. The Motley Fool UK has recommended Electronic Arts. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

Some pros and cons of buying dividend shares for passive income

Dividend shares can seem appealing, but they also carry risks. Christopher Ruane looks at what passive income potential -- and…

Read more »

Housing development near Dunstable, UK
Investing Articles

Down 73%, Vistry’s the worst-performing FTSE 250 share in my portfolio. Time to sell?

Mark Hartley outlines how UK housing market woes have driven down the price of one his core FTSE 250 holdings,…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Just how cheap could IAG shares get this summer?

If the world runs out of jet fuel this summer then IAG shares could take a beating, says Harvey Jones.…

Read more »

Night Takeoff Of The American Space Shuttle
Investing Articles

Up 130% in 2026, can FTSE space stock Filtronic continue to soar?

Edward Sheldon thought that FTSE share Filtronic would do well in 2026. He wasn’t expecting it to shoot up 130%…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

Are investors still using an outdated playbook to value Lloyds shares?

Andrew Mackie looks beyond the standard rate-sensitive narrative around Lloyds shares to question whether we're missing a more resilient earnings…

Read more »

Hydrogen testing at DLR Cologne
Investing Articles

Is £15 the next stop for the Rolls-Royce share price?

Where will the Rolls-Royce share price go from here? Is a £15 price target for the next 12 months totally…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

How much is £7,620 saved in a Cash ISA a decade ago worth today?

Cash ISA savers have received an average of 4% over the last decade, but Harvey Jones says the average Stocks…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

702 shares in this FTSE 100 stalwart earn a £100 a month second income

Unilever shares come with an unusually high dividend yield. Should investors looking for a second income grab the opportunity with…

Read more »